M&A Deal Summary |
|
---|---|
Date | 2019-02-12 |
Target | Ellie Mae |
Sector | Software |
Buyer(s) | Thoma Bravo |
Sellers(s) | Alta Partners |
Deal Type | Secondary Buyout |
Deal Value | 3.7B USD |
Advisor(s) | J.P. Morgan Securities (Financial) Cooley (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1980 |
PE ASSETS | 127.0B USD |
Size | Mega |
Type | Sector Agnostic |
Thoma Bravo is a private equity firm that primarily invests in or acquires US-based middle-market businesses. While Thoma Bravo will consider a variety of transaction situations, including take-privates, buyouts, carve-outs, recapitalizations, and growth equity financings, the Firm has a special interest in tech consolidation opportunities. Target companies generally have a history of profitability with EBITDA of at least $20 million. The Firm's equity commitment size range is $100 to $750 million. Sectors of interest include enterprise and infrastructure software, education, distribution, financial services and consumer goods/services. The Firm will not invest in new inventions or technologies, developmental products or services, start-ups, biotech, motion pictures, distressed businesses, oil/gas, or real estate. Thoma Bravo was formerly known as Thoma Cressey Bravo and before that Golder Thoma & Co. The Firm was originally formed in 1980 and is based in Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 78 of 139 |
Sector (Software) | 35 of 59 |
Type (Secondary Buyout) | 20 of 31 |
State (California) | 20 of 31 |
Country (United States) | 74 of 120 |
Year (2019) | 2 of 11 |
Size (of disclosed) | 11 of 47 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-02-07 |
Aucerna
Calgary, Alberta, Canada Aucerna is a provider of solutions for integrated planning, execution, and reserves in the energy industry. Aucerna is a global source of technology and expertise, serving more than 500 customers from 12 global offices including Calgary, Houston, London, and Singapore. Aucerna serves the energy industry’s largest base of customers, from super-majors and emerging operators to energy investors, consultants, and educational institutions. Aucerna is based in Calgary, Alberta. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-02-25 |
ConnectWise
Tampa, Florida, United States ConnectWise is a provider of software solutions to the Managed Service Provider (MSP) and SMB ecosystem. The company provides the most comprehensive business automation platform in its industry. This includes Professional Services Automation (PSA); Remote Monitoring and Management (RRM); Configure, Price, Quote (CPQ), plus Remote Connection and Security offerings for more than 25,000 partners in more than 65 countries. ConnectWise was founded in 1982 and is based in Tampa, Florida. |
Buy | - |
Category | Venture Capital Firm |
---|---|
Founded | 1996 |
PE ASSETS | 2.6B USD |
Size | Large |
Type | Sector Focused |
Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.
DEAL STATS | # |
---|---|
Overall | 82 of 84 |
Sector (Software) | 4 of 4 |
Type (Secondary Buyout) | 1 of 1 |
State (California) | 40 of 41 |
Country (United States) | 72 of 74 |
Year (2019) | 1 of 1 |
Size (of disclosed) | 1 of 23 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-11-01 |
ViroBay
Menlo Park, California, United States Virobay is a semi-virtual company focused on novel treatments for hepatitis C, pain and auto-immune disease. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-11-30 |
Sunesis
South San Francisco, California, United States Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics for oncology and other serious diseases. Sunesis was founded in 1998 and is based in South San Francisco, California. |
Sell | - |